Halozyme Therapeutics, Inc. (HALO)
67.37
+0.01
(+0.01%)
USD |
NASDAQ |
Mar 06, 16:00
67.98
+0.61
(+0.91%)
After-Hours: 20:00
Halozyme Therapeutics Total Assets (Quarterly) : 2.714B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 199.21B |
| Skye Bioscience, Inc. | 41.32M |
| AIM ImmunoTech, Inc. | 5.494M |
| Stryker Corp. | 47.84B |
| Glaukos Corp. | 930.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.665B |
| Shareholders Equity (Quarterly) | 48.81M |
| Debt to Equity Ratio | 44.60 |
| Current Ratio | 4.660 |
| Net Debt Paydown Yield | -1.70% |